Masimo Co. (NASDAQ:MASI) Short Interest Update

Masimo Co. (NASDAQ:MASI - Get Free Report) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 3,930,000 shares, a decrease of 41.8% from the August 15th total of 6,750,000 shares. Based on an average daily trading volume, of 663,300 shares, the days-to-cover ratio is presently 5.9 days. Currently, 8.0% of the company's stock are sold short.

Hedge Funds Weigh In On Masimo

Hedge funds have recently made changes to their positions in the company. Thrivent Financial for Lutherans boosted its position in Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock valued at $153,314,000 after buying an additional 360,497 shares during the last quarter. Point72 Asset Management L.P. raised its stake in shares of Masimo by 107.8% during the 2nd quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock worth $85,347,000 after buying an additional 351,523 shares during the period. Bamco Inc. NY acquired a new stake in Masimo in the 1st quarter valued at $50,781,000. Schroder Investment Management Group increased its holdings in Masimo by 59.6% in the 4th quarter. Schroder Investment Management Group now owns 877,539 shares of the medical equipment provider's stock worth $102,856,000 after acquiring an additional 327,863 shares in the last quarter. Finally, Westfield Capital Management Co. LP lifted its holdings in Masimo by 35.6% during the fourth quarter. Westfield Capital Management Co. LP now owns 818,476 shares of the medical equipment provider's stock valued at $95,934,000 after purchasing an additional 214,795 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Down 0.2 %

NASDAQ MASI traded down $0.20 on Friday, hitting $112.80. The stock had a trading volume of 591,659 shares, compared to its average volume of 645,620. The business's fifty day moving average price is $114.52 and its 200 day moving average price is $125.61. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. Masimo has a 52-week low of $75.22 and a 52-week high of $153.93. The stock has a market cap of $6.00 billion, a price-to-earnings ratio of 76.50 and a beta of 0.98.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, beating the consensus estimate of $0.77 by $0.09. The firm had revenue of $496.30 million during the quarter, compared to analyst estimates of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. Masimo's revenue was up 9.0% on a year-over-year basis. During the same period last year, the firm posted $0.62 EPS. Equities research analysts anticipate that Masimo will post 3.87 earnings per share for the current year.

Wall Street Analyst Weigh In

MASI has been the subject of a number of recent research reports. Piper Sandler boosted their price objective on shares of Masimo from $160.00 to $165.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research report on Wednesday, August 7th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Masimo presently has an average rating of "Moderate Buy" and a consensus price target of $144.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.